In the current work experiments, MSC treatments (wild type and Sdc3−/−) significantly reduced exudates in the joint cavity and cartilage loss at day 3 following MSC treatment and the overall arthritis index at day 3 post-arthritis induction. The gene discussed is SDC3; the disease is arthritic joint disease.